Navid Mousazadeh

Navid Mousazadeh

Auto-generated profile, based on publicly available information

Navid Mousazadeh

Cancer Gene Therapy Research Center, Zanjan University of Medical Sciences, Zanjan, Iran

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2021 in Nanomedicine
Verified
Journal Article
Closed access
HRHamid Rashidzadeh
Hamid Rashidzadeh
HDHossein Danafar
Hossein Danafar
HRHossein Rahimi
Hossein Rahimi
FMFaezeh Mozafari
Faezeh Mozafari
MSMarziyeh Salehiabar
Marziyeh Salehiabar
MMMehdi Mirsaeidi
Mehdi Mirsaeidi
COVID-19, as an emerging infectious disease, has caused significant mortality and morbidity along with socioeconomic impact. No effective treatment or vaccine has been approved yet for this pandemi... Lay abstract The emergence of COVID-19 has affected millions of people around the world and has become a serious threat to human life. To date, nanotechnology-based tools have been effective in pre...

17 January 2022 in Nanomedicine
Verified
Journal Article
Closed access
NMNavid Mousazadeh
Navid Mousazadeh
MGMahmoud Gharbavi
Mahmoud Gharbavi
HRHamid Rashidzadeh
Hamid Rashidzadeh
HNHamed Nosrati
Hamed Nosrati
HDHossein Danafar
Hossein Danafar
BJBehrooz Johari
Behrooz Johari
Aim: The aim of the present investigation was to develop niosomes containing both curcumin (CUR) and methotrexate (MTX). Also, the combinational effect of CUR and MTX in both free and niosomal form...